ESC

EQS-News: BIO-Europe Spring® 2024 is only a few days away

Retrieved on: 
Wednesday, March 13, 2024

Munich, Germany – March 7, 2024.

Key Points: 
  • Munich, Germany – March 7, 2024.
  • EBD Group is thrilled to welcome the global biopharma community to Barcelona, Spain, March 18–20.
  • Over 3,700 delegates are looking forward to meeting one-to-one to elevate life science partnerships globally.
  • The session “For a greener globe: Biopharma’s journey to a sustainable future” is scheduled for the afternoon on Monday, March 18.

HP Unveils Industry’s Largest Portfolio of AI PCs

Retrieved on: 
Thursday, March 7, 2024

LAS VEGAS, March 07, 2024 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) today announced the industry’s largest portfolio of AI PCs1 leveraging the power of AI to enhance productivity, creativity, and user experiences in hybrid work settings.

Key Points: 
  • HP introduces the industry’s largest portfolio of AI PCs1, featuring new HP Elite PCs, the world’s most advanced business laptops for collaboration,2 and Z by HP mobile workstations to unlock new levels of productivity and creativity.
  • HP announces the AI Creation Center, the world’s most comprehensive workstation solution for AI development3, including Z by HP AI Studio co-engineered with NVIDIA NGC libraries, enabling AI creation.
  • HP now has the largest portfolio of Intel® and AMD-based AI PCs14, demonstrating a commitment to innovation and performance.
  • Accelerate data science capabilities with the HP AI Creation Center, including Z by HP AI Studio
    HP is accelerating the AI era with customized data science solutions.

Multi Board-Certified Physician Sam Setareh Opens MDVIP-Affiliated Primary Care Practice in Los Angeles

Retrieved on: 
Wednesday, February 14, 2024

LOS ANGELES and BOCA RATON, Fla., Feb. 14, 2024 /PRNewswire/ -- MDVIP, the market leader in personalized healthcare with a network of over 1,100 physicians nationwide, today announced the opening of a new MDVIP-affiliated internal medicine practice in Los Angeles. Sam Setareh, M.D., M.S., F.A.C.C., is currently accepting patients who want a more direct relationship with their primary care physician. Dr. Setareh brings an impressive and diversified background to MDVIP, including four board certifications in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Echocardiology, and he is an attending physician at Cedars-Sinai Medical Center in Los Angeles.  Dr. Setareh serves as a member of multiple committees on the American College of Cardiology and the American Heart Association and as a founding member of the editorial board of The Journal of Scientific Innovation in Medicine.

Key Points: 
  • , is currently accepting patients who want a more direct relationship with their primary care physician.
  • Dr. Setareh brings an impressive and diversified background to MDVIP, including four board certifications in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Echocardiology, and he is an attending physician at Cedars-Sinai Medical Center in Los Angeles.
  • "As an MDVIP-affiliated primary care physician, my mission is to help empower patients to take better control of their health through preventive medicine and highly individualized care," said Dr. Setareh, who has subspecialties in preventive cardiology, sports cardiology and advanced cardiovascular imaging.
  • He has treated and taken care of patients from all walks of life, including the most vulnerable to heads-of-state, dignitaries, athletes, celebrities and physician colleagues.

The Future of Single Chamber ICDs: BIOTRONIK Takes Unprecedented Market Stance with Proprietary DX Technology

Retrieved on: 
Monday, February 12, 2024

"We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring," said Ryan Walters, BIOTRONIK US President.

Key Points: 
  • "We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring," said Ryan Walters, BIOTRONIK US President.
  • "Due to DX´s ability to provide additional patient and clinical benefits, it became clear to us that we should be using DX technology with every BIOTRONIK single-chamber ICD."
  • Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.
  • REACT DX registry: Real world REACTion to atrial high rate episodes detected in implantable cardioverter-defibrillator recipients with a DX lead.

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

Retrieved on: 
Wednesday, January 17, 2024

In particular, vasoplegic syndrome (VS), a form of circulatory failure or shock, is routinely seen in these patients and can cause worsened organ failure.

Key Points: 
  • In particular, vasoplegic syndrome (VS), a form of circulatory failure or shock, is routinely seen in these patients and can cause worsened organ failure.
  • In a prior observational study , CytoSorb was associated with the reduced severity of vasoplegia in heart transplant patients, in addition to other clinical benefits.
  • In this prospective, single-center, open-label RCT, 60 heart transplant recipients were randomly assigned to either receive intraoperative CytoSorb hemoadsorption or standard of care.
  • Now, Nemeth, Soltesz, and colleagues have confirmed many of these observations in this rigorous and well-designed groundbreaking randomized controlled trial in orthotopic heart transplant patients.

New Case Study from Charles IT | How a CT Business Took Their IT Program from Lagging to Cutting Edge

Retrieved on: 
Monday, January 29, 2024

MIDDLETOWN, Conn., Jan. 29, 2024 /PRNewswire-PRWeb/ -- When their email system crashed one weekend in 2018, Environmental Systems Corporation (ESC) had to face a fact: They needed help with managing their internal IT. Though ESC consistently provided state-of-the-art technology for buildings and campuses for their customers, there was little time left over to focus on their own IT systems and processes. This deficit left ESC in a position they didn't want to be in—responding to internal events as they were happening rather than preventing what they could. With the crash of an essential system like email, they could no longer continue to ignore their needs and operate in reactive mode. ESC knew that they had to build a proactive plan for internal IT management before another big disruption like this took place.

Key Points: 
  • ESC knew that they had to build a proactive plan for internal IT management before another big disruption like this took place.
  • Before ESC formed its relationship with Charles IT, Mullin considered IT one of the weakest operations at his company.
  • The company's chief operating officer, Michael Mullin, says that Charles IT worked with them to align their priorities and flesh out a plan.
  • "If there's a cutting edge and then kind of a lagging edge and then a middle edge, we were on the back end," Mullin recalls.

Unlocking Ontario's Sustainable Energy Future with Long Duration Energy Storage

Retrieved on: 
Wednesday, January 24, 2024

TORONTO, Jan. 24, 2024 /CNW/ - Today Canada's national trade association for energy storage, Energy Storage Canada (ESC), released a foundational report on the benefits of Long Duration Energy Storage (LDES) in Ontario.

Key Points: 
  • TORONTO, Jan. 24, 2024 /CNW/ - Today Canada's national trade association for energy storage, Energy Storage Canada (ESC), released a foundational report on the benefits of Long Duration Energy Storage (LDES) in Ontario.
  • The report identifies a minimum of 6 gigawatts (GW) of +10-hour duration energy storage starting in 2032.
  • "The IESO needs to capitalize on that momentum and continue future-proofing our energy system by making a clear commitment to procuring cost-saving Long Duration Energy Storage (LDES) resources.
  • Long duration energy storage will save the world economy $540 billion and transform into a trillion-dollar industry by 2040.

ESC Appoints New President

Retrieved on: 
Monday, December 11, 2023

REGINA, Saskatchewan, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) today announced that Clare Colledge will be stepping down from her role as President of its wholly-owned subsidiary, ESC Corporate Services Ltd. (“ESC”), effective December 31, 2023.

Key Points: 
  • REGINA, Saskatchewan, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) today announced that Clare Colledge will be stepping down from her role as President of its wholly-owned subsidiary, ESC Corporate Services Ltd. (“ESC”), effective December 31, 2023.
  • Concurrent with this departure, the Company is pleased to announce that Jeff Fallowfield has been appointed President of ESC, effective January 1, 2024.
  • His focus at ESC will be on leveraging our best-in-class products and solutions and customer service to facilitate ongoing organic growth, maintain operational stability, and support process improvement to ensure continued success for ESC.
  • Today’s announcement reflects that plan.” Peters continued, “Clare has led ESC through a period of strong growth and I want to thank her for her contributions during that time.

LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, November 13, 2023

Under the terms of the agreement, LianBio is entitled to receive a total consideration of $350 million.

Key Points: 
  • Under the terms of the agreement, LianBio is entitled to receive a total consideration of $350 million.
  • In July 2023, LianBio entered into a clinical supply agreement with AstraZeneca in China to procure osimertinib for this clinical trial.
  • In October 2023, LianBio announced that the company’s Board of Directors initiated a comprehensive strategic review of the company, with an update anticipated in the first half of 2024.
  • Cash, cash equivalents, marketable securities and restricted cash at September 30, 2023 totaled $252.2 million compared to $302.4 million as of December 31, 2022.

BECO Holding Company, an H.I.G. Capital Portfolio Company, Completes Two Strategic Acquisitions

Retrieved on: 
Thursday, December 7, 2023

Capital ("H.I.G.

Key Points: 
  • Capital ("H.I.G.
  • As part of the transactions, BHC will support and accelerate the long-term growth initiatives at both businesses and capitalize on commercial synergy opportunities.
  • As market leaders within their respective areas with complementary products and services, these businesses are a natural fit for the BHC platform.
  • We are very excited as we continue to support the BHC team through our partnership and catalyze meaningful growth.”